Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
The global schizophrenia drug market size was US$ 7.9 billion in 2021. The global schizophrenia drug market is forecast to grow to US$ 9.8 billion by 2030, registering a compound annual growth rate ...